Cohort D

BIOLOGICAL2 trials

Sponsors

Institut du Cancer de Montpellier - Val d'Aurelle, Uniquity One (UNI)

Conditions

Breast CancerHealthy

Phase 1

A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy Participants

CompletedNCT06640920

Uniquity One (UNI)Healthy

Start: 2024-04-29End: 2024-10-29Updated: 2025-08-12

Unknown Phase

Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability

RecruitingNCT06382818

Institut du Cancer de Montpellier - Val d'AurelleBreast Cancer

Start: 2025-03-06End: 2038-03-06Target: 854Updated: 2026-03-12